Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus PHENYLEPHRINE HYDROCHLORIDE IN 0 9 SODIUM CHLORIDE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus PHENYLEPHRINE HYDROCHLORIDE IN 0 9 SODIUM CHLORIDE.
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER vs PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Phenylephrine is a selective α1-adrenergic receptor agonist causing vasoconstriction, increasing peripheral vascular resistance and blood pressure.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
Intravenous infusion: initial rate 100-180 mcg/min, titrate to effect; maintenance 40-60 mcg/min. Concentrations: 100 mcg/mL (10 mg in 100 mL NS) or 200 mcg/mL (20 mg in 100 mL NS). Administer via central line preferred.
None Documented
None Documented
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Terminal elimination half-life: 2-3 hours; clinical context: requires repeated dosing or continuous infusion for sustained effect.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Primarily renal (80-90% as unchanged drug and metabolites); minor biliary/fecal elimination (<10%).
Category C
Category A/B
Electrolyte
Electrolyte